Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-08-28 00:00:00 ET · period of report 2025-08-27 · accession 0001415889-25-023209 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-28 | 2025-08-27 | TVTX | Cline Christopher R. | CFO | S - Sale | $17.31 | -470 | 92.7K | -0.5% | -$8,136 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-27 | S | D | 470 | $17.31 | 92,656 | D | — | — |